For immediate release: February 28, 2013 Washington, DC—The federal government recently released regulations that clarify which preventive services will be covered under the Affordable Care Act without cost sharing for … Continued
Michele Robinson came up with the idea for her cancer support group, “You’ll Never Walk Alone,” during her first chemotherapy treatment for ovarian cancer in November 2004. “I was looking … Continued
New research published in Human Reproduction Update provides additional evidence that in vitro fertilization (IVF) does not increase women’s risk for ovarian, endometrial, and cervical cancer. Researchers have wondered if fertility treatments … Continued
In a report issued this month, the American Cancer Society released new statistics on cancer in African Americans. Overall, cancer death rates among both African American men and women have … Continued
A study of the medical records of more than 67,000 women who underwent fertility treatment found that fertility treatments did not effect the risk of breast or uterine cancer, and … Continued
A new study published in Endocrine-Related Cancer which used data from the OCRF-funded Ovarian Cancer Association Consortium, evaluated the association between BMI and ovarian cancer risk, and also examined the association by … Continued
The University of Texas MD Anderson Cancer Center is one of the nation’s preeminent hospitals for cancer care. Located in Houston, Texas, MD Anderson’s Blanton-Davis Ovarian Cancer Research Program was … Continued
A new report from the American Cancer Society estimates cancer incidence and mortality rates for African Americans. In the case of ovarian cancer, both incidence and mortality are lower for … Continued
A new study of mice with prostate cancer indicated that stress can hinder the effectiveness of anti-cancer therapies. In this mouse model, the use of beta-blockers did prevent stress from … Continued
In the journal Clinical Cancer Research, a group of researchers, including current and past OCRF grantees Anil Sood and Gabriel Lopez-Berestein, evaluated the prognostic value of fibroblast growth factor receptor 4 (FGFR4) … Continued
A study of 425 Stage III and IV ovarian cancer patients had either primary debulking surgery or interval debulking surgery. Interval debulking surgery did not appear to increase the risk … Continued
In a study published in the American Journal of Clinical Nutrition, researchers from Curtin University in Australia found that extended breastfeeding significantly reduces the risk of ovarian cancer in women. The … Continued
Get email updates about research news, action alerts, and ways to join the fight.
